Pharma data giant IQVIA has launched a range of solutions called MedTech, offering dedicated tools and services for the medical device and in vitro diagnostics market, and for companies with combination products.
MedTech promises to help companies break down information silos and orchestrate operations across the product lifecycle from concept to market, providing quality control, regulatory, safety and compliance solutions along the way. Geographic scale data technology combined with custom consulting services will help clients drive expansion into global markets while dealing with ever-changing compliance requirements. Specific solutions include Regulatory Intelligence (RID), Regulatory Information Management (RIM) and Enterprise Quality Management (QMS).
MedTech SVP Bhavik Patel (pictured) comments: 'We have served more than 800 MedTech clients in more than 70 countries by delivering an extensive suite of products, services and domain expertise for this space and for our customers' needs. From helping our clients develop and execute clinical trials to entering new markets to managing regulatory processes, IQVIA MedTech supports a company's individual needs worldwide'.
IQVIA, which was formed from the merger of IMS Health and Quintiles and yesterday reported Q1 revenue up 7.2% to $2.684bn, has more than 58,000 employees working in more than 100 countries. Web site: www.iqvia.com/medtech .
All articles 2006-19 written and edited by Mel Crowther and/or Nick Thomas.